Filing Details
- Accession Number:
- 0001209191-22-006384
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-02 16:33:42
- Reporting Period:
- 2022-01-31
- Accepted Time:
- 2022-02-02 16:33:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1763581 | Mark Schoenberg | 400 Alexander Park Drive Princeton NJ 08540 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2022-01-31 | 500 | $0.00 | 22,595 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2022-01-31 | 275 | $7.58 | 22,320 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2022-01-31 | 2,000 | $0.00 | 24,320 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2022-01-31 | 1,099 | $7.58 | 23,221 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Restricted Stock Units | Disposition | 2022-01-31 | 500 | $0.00 | 500 | $0.00 |
Ordinary Shares | Stock Option (right to buy) | Acquisiton | 2022-01-31 | 12,064 | $0.00 | 12,064 | $7.72 |
Ordinary Shares | Restricted Stock Units | Acquisiton | 2022-01-31 | 4,000 | $0.00 | 0 | $0.00 |
Ordinary Shares | Restricted Stock | Disposition | 2022-01-31 | 2,000 | $0.00 | 2,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,000 | No | 4 | M | Direct | ||
12,064 | 2032-01-31 | No | 4 | A | Direct | |
4,000 | No | 4 | A | Direct | ||
4,000 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
- Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 6,000 ordinary shares. 33.33% of the RSUs vested on January 31, 2021 and 8.33% of the remaining RSUs vest in equal quarterly installments thereafter.
- 1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025
- 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025
- The reporting person was granted RSUs on January 31, 2021 representing 6,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022.